Search results
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 16 hours agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19vaccine for the 2024-2025 fall season...
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks via Yahoo Finance· 19 hours agoFor comparison, its industry has an average Forward P/E of 23.51, which means Novavax is trading at...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 6 hours agoPeople 65 and older should get an additional dose 4 months after the previous one, according to the...
Novavax (NASDAQ:NVAX) PT Raised to $18.00
ETF DAILY NEWS· 6 days agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price increased by Bank of America from $12.00 to $18.00 in a research report issued to clients and ...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 4 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 7 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 3 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?